Important Safety Information

Semaglutide

Compounded medications may be prescribed by a licensed provider but are not FDA-approved for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

Boxed warning — risk of thyroid C-cell tumors

GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have ever had thyroid cancer. In rodent studies, GLP-1 medications caused thyroid tumors, including thyroid cancer; it is not known whether they cause thyroid tumors or cancer in humans. Notify your provider promptly if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

When to seek care

Contact your provider as soon as possible and seek in-person care immediately if a side effect becomes problematic or you experience:

• Severe nausea or vomiting leading to dehydration — stay well hydrated while on this medication.
• Kidney problems — dehydration from vomiting, nausea, or diarrhea can worsen pre-existing kidney conditions and, rarely, lead to kidney failure.
• Thyroid C-cell tumor signs — trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
• Pancreatitis — severe pain in your abdomen or back that will not go away, with or without vomiting.
• Acute gallbladder disease — pain in the upper or right abdomen, fever, or yellowing of the eyes or skin.
• Elevated liver enzymes, hepatitis, or jaundice.
• Vision changes, particularly in those with a history of diabetic retinopathy.
• Signs of low blood sugar — dizziness, shakiness, headache, rapid heartbeat, confusion, or sweating (rare; more likely if combined with insulin or a sulfonylurea).
• Increasing heart rate.
• Worsening depression, behavior changes, or suicidal thoughts.

Common side effects

Many people experience no side effects. The most common include:

• Nausea
• Constipation
• Vomiting
• Diarrhea
• Abdominal pain
• Indigestion
• Injection-site reactions
• Headache
• Dizziness
• Fatigue
• Decreased appetite

These symptoms often subside as your body adjusts. Notify your provider if side effects persist. This is not a complete list of side effects.

Drug interactions

Semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar increases when combined with insulin or insulin secretagogues such as sulfonylureas. Semaglutide delays gastric emptying and may affect the absorption of oral medications. If you take thyroid hormone medication, review the timing with your prescriber, as it may need to be adjusted. Medications with narrow therapeutic windows (such as warfarin) should be monitored closely.

Important reminders

• Never share your medication or injection device with another person.
• Tell your provider your full medical history before starting, including any kidney, liver, or pancreas problems.
• Avoid alcohol while taking this medication.
• If you take diabetes medication, talk to your prescribing provider before starting — your doses may need to be adjusted as you lose weight.
• Use adequate contraception. Do not use if pregnant, trying to become pregnant, or breastfeeding; this medication may cause fetal harm. If you plan to become pregnant, it should be stopped at least 2 months beforehand.
• Stop and contact your provider immediately for severe stomach or abdominal pain that will not go away, with or without vomiting.
• Stop and get medical help right away for signs of a serious allergic reaction — swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash; fainting; or very rapid heartbeat. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Tirzepatide

Compounded medications may be prescribed by a licensed provider but are not FDA-approved for safety, effectiveness, or quality. FDA-approved medicines containing tirzepatide are available.

Boxed warning — risk of thyroid C-cell tumors

GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have ever had thyroid cancer. In rodent studies, GLP-1 medications caused thyroid tumors, including thyroid cancer; it is not known whether they cause thyroid tumors or cancer in humans. Notify your provider promptly if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

When to seek care

Contact your provider as soon as possible and seek in-person care immediately if a side effect becomes problematic or you experience:

• Severe nausea or vomiting leading to dehydration — stay well hydrated while on this medication.
• Kidney problems — dehydration from vomiting, nausea, or diarrhea can worsen pre-existing kidney conditions and, rarely, lead to kidney failure.
• Thyroid C-cell tumor signs — trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
• Pancreatitis — severe pain in your abdomen or back that will not go away, with or without vomiting.
• Acute gallbladder disease — pain in the upper or right abdomen, fever, or yellowing of the eyes or skin.
• Elevated liver enzymes, hepatitis, or jaundice.
• Vision changes, particularly in those with a history of diabetic retinopathy.
• Signs of low blood sugar — dizziness, shakiness, headache, rapid heartbeat, confusion, or sweating (rare; more likely if combined with insulin or a sulfonylurea).
• Increasing heart rate.
• Worsening depression, behavior changes, or suicidal thoughts.

Common side effects

Many people experience no side effects. The most common include:

• Nausea
• Constipation
• Vomiting
• Diarrhea
• Abdominal pain
• Indigestion
• Injection-site reactions
• Headache
• Dizziness
• Fatigue
• Decreased appetite

These symptoms often subside as your body adjusts. Notify your provider if side effects persist. This is not a complete list of side effects.

Drug interactions

Tirzepatide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar increases when combined with insulin or insulin secretagogues such as sulfonylureas. Tirzepatide delays gastric emptying and may affect the absorption of oral medications. If you take thyroid hormone medication, review the timing with your prescriber, as it may need to be adjusted. Medications with narrow therapeutic windows (such as warfarin) should be monitored closely.

Important reminders

• Never share your medication or injection device with another person.
• Tell your provider your full medical history before starting, including any kidney, liver, or pancreas problems.
• Avoid alcohol while taking this medication.
• If you take diabetes medication, talk to your prescribing provider before starting — your doses may need to be adjusted as you lose weight.
• Use adequate contraception. Do not use if pregnant, trying to become pregnant, or breastfeeding; this medication may cause fetal harm. If you plan to become pregnant, it should be stopped at least 2 months beforehand.
• Stop and contact your provider immediately for severe stomach or abdominal pain that will not go away, with or without vomiting.
• Stop and get medical help right away for signs of a serious allergic reaction — swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash; fainting; or very rapid heartbeat. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported.

Birth control

Tirzepatide may reduce the effectiveness of oral birth control pills. Talk with your provider before starting if you use birth control; they may recommend a non-oral method or a backup method for 4 weeks after you start and for 4 weeks after each dose increase.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Oral Semaglutide

Compounded medications may be prescribed by a licensed provider but are not FDA-approved for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

Oral semaglutide is a once-daily tablet in the same GLP-1 class as injectable semaglutide. Take it as directed by your provider, typically on an empty stomach with a small sip of water.

Boxed warning — risk of thyroid C-cell tumors

GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have ever had thyroid cancer. In rodent studies, GLP-1 medications caused thyroid tumors, including thyroid cancer; it is not known whether they cause thyroid tumors or cancer in humans. Notify your provider promptly if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

When to seek care

Contact your provider as soon as possible and seek in-person care immediately if a side effect becomes problematic or you experience:

• Severe nausea or vomiting leading to dehydration — stay well hydrated while on this medication.
• Kidney problems — dehydration from vomiting, nausea, or diarrhea can worsen pre-existing kidney conditions and, rarely, lead to kidney failure.
• Thyroid C-cell tumor signs — trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
• Pancreatitis — severe pain in your abdomen or back that will not go away, with or without vomiting.
• Acute gallbladder disease — pain in the upper or right abdomen, fever, or yellowing of the eyes or skin.
• Elevated liver enzymes, hepatitis, or jaundice.
• Vision changes, particularly in those with a history of diabetic retinopathy.
• Signs of low blood sugar — dizziness, shakiness, headache, rapid heartbeat, confusion, or sweating (rare; more likely if combined with insulin or a sulfonylurea).
• Increasing heart rate.
• Worsening depression, behavior changes, or suicidal thoughts.

Common side effects

Many people experience no side effects. The most common include:

• Nausea
• Constipation
• Vomiting
• Diarrhea
• Abdominal pain
• Indigestion
• Headache
• Dizziness
• Fatigue
• Decreased appetite

These symptoms often subside as your body adjusts. Notify your provider if side effects persist. This is not a complete list of side effects.

Drug interactions

Oral Semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar increases when combined with insulin or insulin secretagogues such as sulfonylureas. Oral Semaglutide delays gastric emptying and may affect the absorption of oral medications. If you take thyroid hormone medication, review the timing with your prescriber, as it may need to be adjusted. Medications with narrow therapeutic windows (such as warfarin) should be monitored closely.

Important reminders

• Never share your medication or injection device with another person.
• Tell your provider your full medical history before starting, including any kidney, liver, or pancreas problems.
• Avoid alcohol while taking this medication.
• If you take diabetes medication, talk to your prescribing provider before starting — your doses may need to be adjusted as you lose weight.
• Use adequate contraception. Do not use if pregnant, trying to become pregnant, or breastfeeding; this medication may cause fetal harm. If you plan to become pregnant, it should be stopped at least 2 months beforehand.
• Stop and contact your provider immediately for severe stomach or abdominal pain that will not go away, with or without vomiting.
• Stop and get medical help right away for signs of a serious allergic reaction — swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash; fainting; or very rapid heartbeat. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Microdose Core

Compounded medications may be prescribed by a licensed provider but are not FDA-approved for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide or tirzepatide are available.

Microdose Core pairs a low-dose GLP-1 (semaglutide or tirzepatide) with B12 and a methionine, inositol, and choline ("MIC") blend. The GLP-1 safety information below applies; lower doses are intended for tolerability but carry the same class warnings.

Boxed warning — risk of thyroid C-cell tumors

GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have ever had thyroid cancer. In rodent studies, GLP-1 medications caused thyroid tumors, including thyroid cancer; it is not known whether they cause thyroid tumors or cancer in humans. Notify your provider promptly if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

When to seek care

Contact your provider as soon as possible and seek in-person care immediately if a side effect becomes problematic or you experience:

• Severe nausea or vomiting leading to dehydration — stay well hydrated while on this medication.
• Kidney problems — dehydration from vomiting, nausea, or diarrhea can worsen pre-existing kidney conditions and, rarely, lead to kidney failure.
• Thyroid C-cell tumor signs — trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
• Pancreatitis — severe pain in your abdomen or back that will not go away, with or without vomiting.
• Acute gallbladder disease — pain in the upper or right abdomen, fever, or yellowing of the eyes or skin.
• Elevated liver enzymes, hepatitis, or jaundice.
• Vision changes, particularly in those with a history of diabetic retinopathy.
• Signs of low blood sugar — dizziness, shakiness, headache, rapid heartbeat, confusion, or sweating (rare; more likely if combined with insulin or a sulfonylurea).
• Increasing heart rate.
• Worsening depression, behavior changes, or suicidal thoughts.

Common side effects

Many people experience no side effects. The most common include:

• Nausea
• Constipation
• Vomiting
• Diarrhea
• Abdominal pain
• Indigestion
• Injection-site reactions
• Headache
• Dizziness
• Fatigue
• Decreased appetite

These symptoms often subside as your body adjusts. Notify your provider if side effects persist. This is not a complete list of side effects.

Drug interactions

Microdose Core can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar increases when combined with insulin or insulin secretagogues such as sulfonylureas. Microdose Core delays gastric emptying and may affect the absorption of oral medications. If you take thyroid hormone medication, review the timing with your prescriber, as it may need to be adjusted. Medications with narrow therapeutic windows (such as warfarin) should be monitored closely.

Important reminders

• Never share your medication or injection device with another person.
• Tell your provider your full medical history before starting, including any kidney, liver, or pancreas problems.
• Avoid alcohol while taking this medication.
• If you take diabetes medication, talk to your prescribing provider before starting — your doses may need to be adjusted as you lose weight.
• Use adequate contraception. Do not use if pregnant, trying to become pregnant, or breastfeeding; this medication may cause fetal harm. If you plan to become pregnant, it should be stopped at least 2 months beforehand.
• Stop and contact your provider immediately for severe stomach or abdominal pain that will not go away, with or without vomiting.
• Stop and get medical help right away for signs of a serious allergic reaction — swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash; fainting; or very rapid heartbeat. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported.

B12 + MIC blend

The added B12 and MIC components are generally well tolerated. Mild, temporary effects can include injection-site redness or discomfort, mild nausea, or mild swelling. Do not use the blend if pregnant, nursing, or planning to become pregnant. Stop and contact your provider for an irregular heartbeat or difficulty breathing.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Microdose Energy & Focus

Compounded medications may be prescribed by a licensed provider but are not FDA-approved for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide or tirzepatide are available.

Microdose Energy & Focus pairs a low-dose GLP-1 (semaglutide or tirzepatide) with NAD+ and B12. The GLP-1 safety information below applies; lower doses are intended for tolerability but carry the same class warnings.

Boxed warning — risk of thyroid C-cell tumors

GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have ever had thyroid cancer. In rodent studies, GLP-1 medications caused thyroid tumors, including thyroid cancer; it is not known whether they cause thyroid tumors or cancer in humans. Notify your provider promptly if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.

When to seek care

Contact your provider as soon as possible and seek in-person care immediately if a side effect becomes problematic or you experience:

• Severe nausea or vomiting leading to dehydration — stay well hydrated while on this medication.
• Kidney problems — dehydration from vomiting, nausea, or diarrhea can worsen pre-existing kidney conditions and, rarely, lead to kidney failure.
• Thyroid C-cell tumor signs — trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
• Pancreatitis — severe pain in your abdomen or back that will not go away, with or without vomiting.
• Acute gallbladder disease — pain in the upper or right abdomen, fever, or yellowing of the eyes or skin.
• Elevated liver enzymes, hepatitis, or jaundice.
• Vision changes, particularly in those with a history of diabetic retinopathy.
• Signs of low blood sugar — dizziness, shakiness, headache, rapid heartbeat, confusion, or sweating (rare; more likely if combined with insulin or a sulfonylurea).
• Increasing heart rate.
• Worsening depression, behavior changes, or suicidal thoughts.

Common side effects

Many people experience no side effects. The most common include:

• Nausea
• Constipation
• Vomiting
• Diarrhea
• Abdominal pain
• Indigestion
• Injection-site reactions
• Headache
• Dizziness
• Fatigue
• Decreased appetite

These symptoms often subside as your body adjusts. Notify your provider if side effects persist. This is not a complete list of side effects.

Drug interactions

Microdose Energy & Focus can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar increases when combined with insulin or insulin secretagogues such as sulfonylureas. Microdose Energy & Focus delays gastric emptying and may affect the absorption of oral medications. If you take thyroid hormone medication, review the timing with your prescriber, as it may need to be adjusted. Medications with narrow therapeutic windows (such as warfarin) should be monitored closely.

Important reminders

• Never share your medication or injection device with another person.
• Tell your provider your full medical history before starting, including any kidney, liver, or pancreas problems.
• Avoid alcohol while taking this medication.
• If you take diabetes medication, talk to your prescribing provider before starting — your doses may need to be adjusted as you lose weight.
• Use adequate contraception. Do not use if pregnant, trying to become pregnant, or breastfeeding; this medication may cause fetal harm. If you plan to become pregnant, it should be stopped at least 2 months beforehand.
• Stop and contact your provider immediately for severe stomach or abdominal pain that will not go away, with or without vomiting.
• Stop and get medical help right away for signs of a serious allergic reaction — swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash; fainting; or very rapid heartbeat. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported.

NAD+ and B12

The added NAD+ and B12 are generally well tolerated. Mild, temporary effects can include injection-site reactions, flushing or warmth, lightheadedness, or mild nausea — more likely if an injection is given too quickly, so administer slowly. Do not use if pregnant, nursing, or planning to become pregnant.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

NAD+

NAD+ formulations are compounded and prescribed off-label by licensed providers and are not FDA-approved.

NAD+ is offered as a subcutaneous injection or a nasal spray. Side effects are generally mild and short-lived; rotate injection sites and follow your provider's guidance to reduce irritation.

Common side effects

• Injection: redness, tenderness, or soreness at the injection site; mild flushing or warmth; lightheadedness; temporary fatigue; mild nausea.
• Nasal spray: nasal dryness or irritation, sneezing or a transient burning sensation, headache, mild dizziness.

More serious side effects (less common)

• Allergic reaction (rash, swelling, shortness of breath).
• Dizziness or fainting, especially after an injection.
• Persistent fatigue or flu-like symptoms.
• Flushing with a rapid heartbeat.

If you have signs of an allergic reaction or severe discomfort, stop treatment and seek medical care immediately.

Warnings

• Do not exceed the dose prescribed by your provider.
• Inject subcutaneously using proper technique; improper technique may increase irritation.
• Use nasal formulations carefully to avoid irritation or overuse.
• Individuals with autoimmune, cardiovascular, or metabolic conditions should be monitored more closely.

Do not use if

• You have a known hypersensitivity to NAD+ or any formulation component.
• You are pregnant or breastfeeding.
• You have an active infection, uncontrolled chronic illness, or ongoing cancer treatment, without prior approval from your specialist.

Drug interactions

No widely reported drug interactions, but NAD+ may affect oxidative metabolism. Use caution with medications that affect energy metabolism, including insulin, metformin, or corticosteroids. Disclose all prescription medications, supplements, and herbal products to your provider.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Sermorelin

Sermorelin is compounded and prescribed off-label by licensed providers and is not FDA-approved.

Side effects are typically mild and resolve over time.

Common side effects

• Pain, redness, or swelling at the injection site.
• Fatigue or mild dizziness.
• Flushing, headache, or transient restlessness.

Warnings

Sermorelin may affect hormone levels and metabolism, so periodic monitoring is important. Use caution if you have a history of metabolic or endocrine conditions. Though rare, allergic reactions are possible — seek care for rash, swelling, or trouble breathing.

Do not use if

• You have a known hypersensitivity to sermorelin or any of its ingredients.
• You are pregnant, planning to become pregnant, or breastfeeding.
• You have active cancer or a history of cancer that is not in remission.

Drug interactions

Sermorelin may interact with glucocorticoids (such as prednisone), which can blunt growth-hormone stimulation, and with thyroid medications, which may alter hormonal balance. Always tell your provider about all medications and supplements you take.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

B12-MIC

B12-MIC is compounded and prescribed off-label by licensed providers and is not FDA-approved.

B12-MIC combines vitamin B12 with methionine, inositol, and choline. Side effects are typically mild and resolve over time.

Common side effects

• Discomfort or redness at the injection site.
• Itching or a sensation of mild swelling.
• Muscle cramps or weakness.
• Nausea or changes in urination.
• Swelling around the ankles or feet.
• Fatigue.

Precautions

• Do not use if you are pregnant, nursing, or planning to become pregnant or breastfeed.
• If itching or irritation persists, an over-the-counter hydrocortisone cream may help, or stop use.
• In the uncommon event of a more serious reaction such as an irregular heartbeat or difficulty breathing, stop use immediately and contact your provider.

Please consult the medication packaging for a full list of side effects, warnings, interactions, and additional information. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In case of emergency, call 911 or go to the nearest emergency room.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.